Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -53,079 | -135,682 | -66,611 | 130,133 | 181,271 |
| Depreciation Amortization | 3,585 | 2,532 | 1,268 | 5,119 | 32,444 |
| Income taxes - deferred | N/A | N/A | N/A | -6,014 | -6,014 |
| Accounts receivable | 52,201 | 25,656 | 26,397 | -50,608 | -50,917 |
| Accounts payable and accrued liabilities | 14,281 | 32,532 | 15,137 | 20,097 | -645 |
| Other Working Capital | 61,133 | 54,508 | 38,857 | -58,287 | -80,262 |
| Other Operating Activity | -186,851 | -47,898 | -37,102 | 73,367 | 62,301 |
| Operating Cash Flow | $-108,730 | $-68,352 | $-22,054 | $113,807 | $138,178 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 176,303 | 120,852 | 42,778 | -155,785 | -46,387 |
| PPE Investments | -33 | N/A | N/A | -70 | -70 |
| Sale Of Investment | 160,385 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $336,655 | $120,852 | $42,778 | $-155,855 | $-46,457 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -210,760 | -643 | -321 | -1,285 | -963 |
| Common Stock Repurchased | -1,026 | -1,026 | -923 | -941 | -941 |
| Financing Cash Flow | $-211,786 | $-1,669 | $-1,244 | $-2,226 | $-1,904 |
| Beginning Cash Position | 36,112 | 36,112 | 36,112 | 80,386 | 80,386 |
| End Cash Position | 52,251 | 86,943 | 55,592 | 36,112 | 170,203 |
| Net Cash Flow | $16,139 | $50,831 | $19,480 | $-44,274 | $89,817 |
| Free Cash Flow | |||||
| Operating Cash Flow | -108,730 | -68,352 | -22,054 | 113,807 | 138,178 |
| Capital Expenditure | -33 | N/A | N/A | -70 | -70 |
| Free Cash Flow | -108,763 | -68,352 | -22,054 | 113,737 | 138,108 |